PRECISION MEDICINE

NGS Clinically Useful for Pediatric Cancers

The Precision in Pediatric Sequencing (PIPseq) Program at Columbia University Medical Center released data on its first 100 patients, which shows that integrating clinical next-generation sequencing … [Read more...]

TESTING GUIDELINES

Joint Guideline Issued for CRC Molecular Testing

A joint guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology, published in the … [Read more...]

PRECISION MEDICINE

Study Shows Benefits of Large-Scale, Clinical Sequencing Initiatives

Large-scale sequencing initiatives performed in integrated health care systems, such as the DiscovEHR collaboration, can advance genetic discovery and serve as a "blueprint" for adoption of … [Read more...]

TESTING

Testing Guidelines at a Glance

New Definition for Abnormal Liver Chemistry For the first time, the American College of Gastroenterology issued a practice guideline to define a healthy serum alanine aminotransferase (ALT) level. … [Read more...]

SPECIAL FOCUS: PEDIATRICS

Sequencing Pediatric Cancer Provides Clinically Useful Information

The Precision in Pediatric Sequencing (PIPseq) Program at Columbia University Medical Center released data on its first 100 patients, which shows that integrating clinical next-generation sequencing … [Read more...]

GENETIC TESTING

Many Breast Cancer Patients Not Referred for Genetic Testing; Genetic Counseling Needed

Physicians often fail to recommend genetic testing for breast cancer patients at high risk for mutations, according to a research letter published Feb. 7 in the Journal of the American Medical … [Read more...]

PRECISION MEDICINE

Discordant Commercial, Next-Gen Tumor Profiling Results May be Clinically Relevant

Next-generation sequencing is increasingly becoming commonplace to match cancer-associated alterations with targeted treatments. But, a new study raises concerns that marked differences in results … [Read more...]

EMERGING TESTS

Blood-based, Proteomic Test May ID Preterm Delivery Risk, Saving Infant Lives, Costs

The use of a novel test for identifying pregnant women at risk of spontaneous preterm birth risk could improve infant outcomes and reduce the overall economic impact of preterm birth, according to a … [Read more...]

INVESTMENT

Dx Investments Hold Steady in 2016, Number of Exits Declines

Investments in the diagnostics and tools (Dx/Tools) sector remained steady in 2016, according to Silicon Valley Bank's annual report, Trends in Healthcare Investments and Exits 2017. The report … [Read more...]

TESTING STRATEGY

Study Reveals Resistance to Change in Cervical Cancer Screenings

The majority of women are willing to undergo less frequent cervical cancer screening, consistent with screening guidelines, if it was recommended by their health care provider, according to a study … [Read more...]


(-0000g2)